Current Approaches to Renovascular Hypertension

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

This article examines the status regarding prevalence, mechanisms, clinical manifestations and management of renovascular hypertension at this point in time. It should be viewed as a work in progress. As with most complex conditions, clinicians must integrate the results of published literature studies while considering each patient's specific features and comorbid disease risks. Beyond identifying renovascular disease as a cause of secondary hypertension, one must manage renal artery stenosis (RAS) itself as an atherosclerotic vascular complication. This disease warrants follow-up regarding progression and potential for ischemic tissue injury. These elements often determine the role and timing for revascularization. In this respect, atherosclerotic renal artery stenosis is analogous to progressive carotid or aortic aneurysmal disease.

Original languageEnglish (US)
Pages (from-to)717-732
Number of pages16
JournalMedical Clinics of North America
Volume93
Issue number3
DOIs
StatePublished - May 2009

Fingerprint

Renovascular Hypertension
Renal Artery Obstruction
Aortic Diseases
Blood Vessels
Hypertension
Wounds and Injuries

Keywords

  • ACE inhibitor
  • Angioplasty
  • Angiotensin receptor blocker
  • Renal artery stenosis
  • Renovascular hypertension
  • Stent

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Current Approaches to Renovascular Hypertension. / Textor, Stephen C.

In: Medical Clinics of North America, Vol. 93, No. 3, 05.2009, p. 717-732.

Research output: Contribution to journalArticle

@article{57ce2d0452b34f2ba4d997d184fa90d2,
title = "Current Approaches to Renovascular Hypertension",
abstract = "This article examines the status regarding prevalence, mechanisms, clinical manifestations and management of renovascular hypertension at this point in time. It should be viewed as a work in progress. As with most complex conditions, clinicians must integrate the results of published literature studies while considering each patient's specific features and comorbid disease risks. Beyond identifying renovascular disease as a cause of secondary hypertension, one must manage renal artery stenosis (RAS) itself as an atherosclerotic vascular complication. This disease warrants follow-up regarding progression and potential for ischemic tissue injury. These elements often determine the role and timing for revascularization. In this respect, atherosclerotic renal artery stenosis is analogous to progressive carotid or aortic aneurysmal disease.",
keywords = "ACE inhibitor, Angioplasty, Angiotensin receptor blocker, Renal artery stenosis, Renovascular hypertension, Stent",
author = "Textor, {Stephen C}",
year = "2009",
month = "5",
doi = "10.1016/j.mcna.2009.02.012",
language = "English (US)",
volume = "93",
pages = "717--732",
journal = "Medical Clinics of North America",
issn = "0025-7125",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Current Approaches to Renovascular Hypertension

AU - Textor, Stephen C

PY - 2009/5

Y1 - 2009/5

N2 - This article examines the status regarding prevalence, mechanisms, clinical manifestations and management of renovascular hypertension at this point in time. It should be viewed as a work in progress. As with most complex conditions, clinicians must integrate the results of published literature studies while considering each patient's specific features and comorbid disease risks. Beyond identifying renovascular disease as a cause of secondary hypertension, one must manage renal artery stenosis (RAS) itself as an atherosclerotic vascular complication. This disease warrants follow-up regarding progression and potential for ischemic tissue injury. These elements often determine the role and timing for revascularization. In this respect, atherosclerotic renal artery stenosis is analogous to progressive carotid or aortic aneurysmal disease.

AB - This article examines the status regarding prevalence, mechanisms, clinical manifestations and management of renovascular hypertension at this point in time. It should be viewed as a work in progress. As with most complex conditions, clinicians must integrate the results of published literature studies while considering each patient's specific features and comorbid disease risks. Beyond identifying renovascular disease as a cause of secondary hypertension, one must manage renal artery stenosis (RAS) itself as an atherosclerotic vascular complication. This disease warrants follow-up regarding progression and potential for ischemic tissue injury. These elements often determine the role and timing for revascularization. In this respect, atherosclerotic renal artery stenosis is analogous to progressive carotid or aortic aneurysmal disease.

KW - ACE inhibitor

KW - Angioplasty

KW - Angiotensin receptor blocker

KW - Renal artery stenosis

KW - Renovascular hypertension

KW - Stent

UR - http://www.scopus.com/inward/record.url?scp=65149084294&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65149084294&partnerID=8YFLogxK

U2 - 10.1016/j.mcna.2009.02.012

DO - 10.1016/j.mcna.2009.02.012

M3 - Article

C2 - 19427501

AN - SCOPUS:65149084294

VL - 93

SP - 717

EP - 732

JO - Medical Clinics of North America

JF - Medical Clinics of North America

SN - 0025-7125

IS - 3

ER -